Did the FDA Sabotage a Non-Addictive Pain Killer? (Guest: Charles L. Hooper) episode artwork

EPISODE · Jul 12, 2023 · 35 MIN

Did the FDA Sabotage a Non-Addictive Pain Killer? (Guest: Charles L. Hooper)

from Health Care News Podcast · host AnneMarie Schieber

Did the FDA destroy what could have been a non-addictive pain killer that might have staved off the opioid crisis before it ever stood a chance? Several decades ago, the agency approved the drug Toradol, the first non-addictive pain killer that had pain killing effects of morphine without the addictive potential. However, the FDA set the desired peak dosage, known as the loading dose, far higher than manufacturer Syntex desired. The company reluctantly complied. 97 people prescribed Toradol dies within the first few years as a result.  With their drug no longer used in it’s original form, pharmaceutical company Syntex tried to introduce the drug in an oral form. However, the FDA overcompensated for their initial error, restricting dosage to levels not useful for medicinal applications  Today’s guest, Charles L. Hooper worked at Syntex when Toradol was coming onto the market as a nonsteroidal anti-inflammatory drug. This was a time of excitement for the company says Hooper. They were eager to cooperate with the FDA for a successful launch. What went wrong? Hooper discusses how a decision on something like the “loading dose” can come down to a single person, and people are fallible. The FDA’s position of final the final say had disastrous consequences, leading credence to the position that they should act as a “guiding agency. Even with all the FDA’s power and authority, nothing is a certainty. On April 19, 2023, when asked about the opioid crisis, FDA Commissioner Robert Califf told the Senate Appropriations subcommittee it would help if pharma could develop a “non-addictive” pain medicine. “It is a tough job, but we are not successful in having nonaddictive pain medicines coming through the pipeline. We need to do everything we can do to push industry and make this happen.” Learn more here: FDA Commissioner Called Out for Remark on Non-Addictive PainkillersRead Charles Hooper’s article in the Wall Street Journal for more: How the FDA Helped Fuel the Opioid Epidemic

Did the FDA destroy what could have been a non-addictive pain killer that might have staved off the opioid crisis before it ever stood a chance? Several decades ago, the agency approved the drug Toradol, the first non-addictive pain killer that had pain killing effects of morphine without the addictive potential. However, the FDA set the desired peak dosage, known as the loading dose, far higher than manufacturer Syntex desired. The company reluctantly complied. 97 people prescribed Toradol dies within the first few years as a result.  With their drug no longer used in it’s original form, pharmaceutical company Syntex tried to introduce the drug in an oral form. However, the FDA overcompensated for their initial error, restricting dosage to levels not useful for medicinal applications  Today’s guest, Charles L. Hooper worked at Syntex when Toradol was coming onto the market as a nonsteroidal anti-inflammatory drug. This was a time of excitement for the company says Hooper. They were eager to cooperate with the FDA for a successful launch. What went wrong? Hooper discusses how a decision on something like the “loading dose” can come down to a single person, and people are fallible. The FDA’s position of final the final say had disastrous consequences, leading credence to the position that they should act as a “guiding agency. Even with all the FDA’s power and authority, nothing is a certainty. On April 19, 2023, when asked about the opioid crisis, FDA Commissioner Robert Califf told the Senate Appropriations subcommittee it would help if pharma could develop a “non-addictive” pain medicine. “It is a tough job, but we are not successful in having nonaddictive pain medicines coming through the pipeline. We need to do everything we can do to push industry and make this happen.” Learn more here: FDA Commissioner Called Out for Remark on Non-Addictive PainkillersRead Charles Hooper’s article in the Wall Street Journal for more: How the FDA Helped Fuel the Opioid Epidemic

NOW PLAYING

Did the FDA Sabotage a Non-Addictive Pain Killer? (Guest: Charles L. Hooper)

0:00 35:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Breaking News Show | eTurboNews Juergen Thomas Steinmetz News is relevant to the global travel and tourism industry, human rights and global issues.Breaking news when it happens and only from the source. Eat to Live Jenna Fuhrman, Dr. Fuhrman Our health is our most precious gift and smart nutrition can change your life. Each month, join Dr. Fuhrman and his daughter, Jenna Fuhrman as they discuss important topics in the world of nutrition. Eat to Live will change the way you eat and think about food. That Hoarder: Overcome Compulsive Hoarding That Hoarder Hoarding disorder is stigmatised and people who hoard feel vast amounts of shame. This podcast began life as an audio diary, an anonymous outlet for somebody with this weird condition. That Hoarder speaks about her experiences living with compulsive hoarding, she interviews therapists, academics, researchers, children of hoarders, professional organisers and influencers, and she shares insight and tips for others with the problem. Listened to by people who hoard as well as those who love them and those who work with them, Overcome Compulsive Hoarding with That Hoarder aims to shatter the stigma, share the truth and speak openly and honestly to improve lives. The Small Business Startup School – Business Notes | Financial Literacy | Retail Psychology – For Professionals & Entrepreneurs The Small Business Startup School Inc. Starting or buying a small business? While personal circumstances may vary, business patterns remain timeless. On The Small Business Startup School, we explore strategies, insights, and practical solutions to help entrepreneurs confidently navigate their journey.Hosted by Ola Williams—a retail entrepreneur, fintech founder, and financial coach with over two decades of experience—this podcast marries financial awareness and retail psychology with optimism to deliver actionable takeaways.Join us to learn, grow, and connect as we uncover the keys to business success.Let’s continue to learn together and be encouraged to keep on connecting!

Frequently Asked Questions

How long is this episode of Health Care News Podcast?

This episode is 35 minutes long.

When was this Health Care News Podcast episode published?

This episode was published on July 12, 2023.

What is this episode about?

Did the FDA destroy what could have been a non-addictive pain killer that might have staved off the opioid crisis before it ever stood a chance? Several decades ago, the agency approved the drug Toradol, the first non-addictive pain killer that had...

Can I download this Health Care News Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!